COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important anti-inflammatory role in preventing severe forms of COVID -19 in patients with DM2.
CITATION STYLE
Martorina, W. J., & Tavares, A. (2021). Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus. Revista Da Associacao Medica Brasileira (1992), 67Suppl 1(Suppl 1), 18–21. https://doi.org/10.1590/1806-9282.67.Suppl1.20200968
Mendeley helps you to discover research relevant for your work.